Why the study?
Outcomes of complex percutaneous coronary interventions in older patients remained debated.
Does percutaneous coronary intervention with ultrathin stents for unprotected left main or bifurcation lesions yield similar clinical outcomes in octogenarians compared to younger patients?
Does percutaneous coronary intervention with ultrathin stents for unprotected left main or bifurcation lesions yield similar clinical outcomes in octogenarians compared to younger patients?
Complex PCI with ultrathin stents in octogenarians yields similar midterm cardiovascular outcomes compared to younger patients, though all-cause mortality is higher due to non-cardiovascular causes.
Answers are grounded in this paper and cite their sources.
Octogenarian complex PCI with ultrathin stents warrants cautious consideration; leaves open need for randomized age-specific trials.
OBJECTIVE: Outcomes of complex percutaneous coronary interventions (PCIs) in older patients are still debated. The aim of the study was to evaluate clinical outcomes of Octogenarian patients treated with ultrathinstents on left main or on coronary bifurcations, compared with younger patients. METHODS: All consecutive patients presenting a critical lesion of an unprotected left main (ULM) or a bifurcation and treated with very thin stents were included in the RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life) registry and divided into octogenarians group (OG, 551 patients) and nonoctogenarians (NOGs, 2,453 patients). Major adverse cardiovascular event (MACE), a composite end point of all-cause death, nonfatal myocardial infarction (MI), target lesion revascularization (TLR), and stent thrombosis (ST), was the primary endpoint, while MACE components, cardiovascular (CV) death, and target vessel revascularization (TVR) were the secondary ones. RESULTS: Indication for PCI was acute coronary syndrome in 64.7% of the OG versus 53.1% of the NOG. Severe calcifications and a diffuse disease were significantly more in OG. After a follow-up of 15.2 ± 10.3 months, MACEs were higher in the OG than in the NOG patients (OG 19.1% vs. NOG 11.2%, p < .001), along with MI (OG 6% vs. NOG 3.4%, p = .002) and all-cause death (OG 14% vs. NOG 4.3%, p < .001). In contrast, no significant difference was detected in CV-death (OG 5.1% vs. NOG 4%, p = .871), TVR/TLR, or ST. At multivariate analysis, age was not an independent predictor of MACE (OR 1.02 CI 95% 0.76-1.38), while it was for all-cause death, along with diabetes, GFR < 60 ml/min, and ULM disease. DISCUSSION: Midterm outcomes of complex PCI in OG are similar to those of younger patients. However, due to the higher non-CV death rate, accurate patient selection is mandatory.
No takes yet. Share an insight, caveat, or question.
Conrotto et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: